CJC-1295 No DAC

CJC-1295 No DAC for Research Use

CJC-1295 No DAC is a GHRH analogue studied in growth-hormone secretagogue and pituitary signalling research. This PeptideLabs product page is structured for researchers who need clear specifications, compliant handling notes, and context for designing controlled laboratory experiments. The material is supplied strictly for research use only and is not intended for human or veterinary administration, diagnostic use, therapeutic use, or consumer application.

The main purpose of this page is to help laboratory buyers evaluate CJC-1295 No DAC as a research material rather than as a medical product. The content below explains the scientific background, proposed research mechanisms, typical application areas, storage expectations, reconstitution considerations where applicable, and quality-control points that support careful experimental planning.

Scientific Overview of CJC-1295 No DAC

CJC-1295 No DAC is positioned for controlled research programs focused on GHRH analogue studied in growth-hormone secretagogue and pituitary signalling research. Researchers usually select this material when a defined compound or peptide profile is needed for repeatable assays, comparison studies, or exploratory pathway research. Because experimental outcomes depend on model design, concentration selection, solvent system, controls, storage history, and analytical endpoints, all conclusions should be drawn only within the limits of the laboratory protocol.

CJC-1295 No DAC Mechanism of Action in Research Models

CJC-1295 No DAC is evaluated in models focused on GHRH receptor signalling, pulsatile GH-marker research, pituitary-response assays and secretagogue comparison studies. These mechanisms are described as research areas, not clinical outcomes. The correct interpretation of any result depends on the biological model, assay sensitivity, positive and negative controls, exposure period, analytical method, and the reproducibility of the dataset.

Mechanism-focused studies may include receptor-pathway assays, biomarker panels, gene-expression analysis, protein-expression studies, cell-viability controls, migration assays, metabolic marker analysis, or stability testing. Researchers should document the material lot, preparation method, solvent, concentration range, storage condition, and timing of each experiment so that data can be reviewed and repeated.

Research Applications

CJC-1295 No DAC is suitable for research programs where the investigator needs a clearly identified material and a focused scientific rationale. It may be used as a standalone research item or as part of a broader comparison matrix with related peptides and laboratory supplies from PeptideLabs.

Common laboratory research areas include:

• GHRH receptor-pathway research
• GH secretagogue comparison studies
• pituitary cell signalling assays
• combination research with Ipamorelin
• analytical purity, solubility and handling observations
• comparative research with Ipamorelin, Sermorelin, CJC + Ipamorelin and Tesamorelin

Researchers who are building a multi-product study can use internal links to map peptide families by category. For example, recovery-pathway studies may compare BPC-157, TB-500 and GHK-Cu; mitochondrial studies may compare MOTS-c, SS-31 (Elamipretide) and NAD+ Injectable; and secretagogue studies may compare CJC-1295 No DAC, Ipamorelin and Sermorelin.

Product Specifications

• Product name: CJC-1295 No DAC
• CAS number: 863288-34-0
• Purity: ≥99%
• Form: Lyophilised powder
• Recommended storage: -20°C
• Use classification: Research use only

These specifications support receiving inspection, inventory records, study design, and internal documentation. If a certificate of analysis or batch-specific document is available, researchers should keep it with the study file and cross-check product identity, purity, appearance, and lot details before use.

Storage and Handling Information

CJC-1295 No DAC should be stored according to the product specification, with -20°C used as the primary reference from the PeptideLabs catalog data. Lyophilised peptide materials are generally protected from unnecessary heat, moisture, and repeated freeze-thaw exposure. Researchers should keep vials sealed until preparation and allow cold materials to equilibrate before opening when condensation risk is present.

All handling should follow institutional laboratory safety procedures. This includes appropriate personal protective equipment, clean preparation surfaces, labelled containers, controlled disposal, and accurate record keeping. If the material is moved between storage locations, the transfer time and temperature exposure should be documented.

Reconstitution and Preparation Notes

CJC-1295 No DAC may require reconstitution before certain research workflows. The solvent system should be chosen by the investigator based on the assay design, compatibility requirements, and institutional protocol. PeptideLabs also carries Bac Water 10ml and Bac Water 3ml for laboratories that require bacteriostatic water as part of a peptide-preparation workflow.

Preparation records should include product name, lot number, solvent, target concentration, date prepared, storage temperature, operator initials, and intended assay. Gentle mixing is typically preferred over aggressive agitation for peptide solutions. This section is not dosage guidance and must not be interpreted as instructions for administration.

External Research Resources

For independent literature discovery, researchers can review a PubMed literature search for CJC-1295 No DAC and compare findings with their own protocol, controls, and institutional review process.

Quality Assurance and Documentation

Quality assurance for CJC-1295 No DAC includes both the supplied material and the way the laboratory handles it after receipt. Researchers should inspect the vial, confirm product identity, review available purity information, verify storage conditions, and record all preparation details before starting experiments.

For stronger data integrity, studies should include suitable controls, repeat measurements, documented acceptance criteria, and a clear distinction between exploratory findings and validated conclusions. Internal linking between related PeptideLabs products supports topical navigation, but scientific decisions should always be based on the study objective and protocol.

CJC-1295 No DAC FAQ

What is CJC-1295 No DAC used for in research?

CJC-1295 No DAC is used in laboratory studies involving GHRH analogue studied in growth-hormone secretagogue and pituitary signalling research. It is supplied for research use only.

Is CJC-1295 No DAC intended for human use?

No. CJC-1295 No DAC is not intended for human or veterinary use, treatment, diagnosis, supplementation, cosmetic application, or self-administration.

Does PeptideLabs provide dosage instructions?

No. Because CJC-1295 No DAC is a research-use-only material, PeptideLabs does not provide dosage, cycle, administration, or treatment instructions.

How should CJC-1295 No DAC be stored?

The catalog storage reference for this product is -20°C. Researchers should also follow their institutional protocol and any batch-specific documentation.

Can CJC-1295 No DAC be compared with related peptides?

Yes. Researchers may compare CJC-1295 No DAC with materials such as Ipamorelin, Sermorelin, CJC + Ipamorelin, and Tesamorelin when the study design supports that comparison.

What records should be kept for this product?

Recommended records include product name, lot number, supplier, receipt date, storage conditions, solvent, concentration, preparation date, assay use, and disposal notes.

Research Use Only

CJC-1295 No DAC is supplied strictly for in-vitro laboratory research. It is not intended for human or veterinary use, diagnosis, treatment or self-administration. Handle only in accordance with applicable laboratory procedures and institutional protocols.